Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Colorcon
Merck
Johnson and Johnson

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Collagenase - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for collagenase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University Hospital, GhentEarly Phase 1
Men's Health BostonPhase 4
Fibrocell Technologies, Inc.Phase 1/Phase 2

See all collagenase clinical trials

Recent Litigation for collagenase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC2018-11-09
Allergan USA Inc v. Medicis Aesthetics Inc2013-09-13
TerreStar Networks Inc.2010-10-19

See all collagenase litigation

PTAB Litigation
PetitionerDate
Avita Medical Limited2017-04-04

See all collagenase litigation

Pharmacology for collagenase
Ingredient-typeCollagenases

Company Disclosures: US Patents for collagenase

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures of Curacao (Curacao, AN) 2039-03-29 RX company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Auxilium US Holdings, LLC (Wilmington, DE) 2026-01-30 RX company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures Corporation (Lynbrook, NY) 2039-02-26 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for collagenase

These patents were identified by searching patent claims

Supplementary Protection Certificates for collagenase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2010 Austria   Start Trial PRODUCT NAME: AGALSIDASE ALPHA; REGISTRATION NO/DATE: EU/1/01/189/001 20010803
2013020 Lithuania   Start Trial PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
02C/023 Belgium   Start Trial PRODUCT NAME: ANAKINRA; REGISTRATION NO/DATE: EU/1/02/203/001 20020311
00627 Netherlands   Start Trial PRODUCT NAME: METHOD FOR PRODUCING SECRETED PROTIENS; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKesson
Colorcon
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.